Talazoparib tosylateProduct ingredient for Talazoparib

Name
Talazoparib tosylate
Drug Entry
Talazoparib

Talazoparib is an inhibitor of mammalian polyadenosine 5’-diphosphoribose polymerases (PARPs), enzymes responsible for regulating essential cellular functions, such as DNA transcription and DNA repair.4

Developed by Pfizer, talazoparib was first approved by the FDA in October 2018 2 and by the EMA in June 2019.5 It was approved by Health Canada in September 2020.6 Talazoparib is currently used in the treatment of BRCA-mutated breast cancer and HRR-mutated prostate cancer.4,6,7

Accession Number
DBSALT002816
Structure
Synonyms
Not Available
External IDs
BMN 673TS / BMN-673TS
UNII
02WK9U5NZC
CAS Number
1373431-65-2
Weight
Average: 552.56
Monoisotopic: 552.139130712
Chemical Formula
C26H22F2N6O4S
InChI Key
QUQKKHBYEFLEHK-QNBGGDODSA-N
InChI
InChI=1S/C19H14F2N6O.C7H8O3S/c1-27-18(22-8-23-27)15-16(9-2-4-10(20)5-3-9)24-13-7-11(21)6-12-14(13)17(15)25-26-19(12)28;1-6-2-4-7(5-3-6)11(8,9)10/h2-8,15-16,24H,1H3,(H,26,28);2-5H,1H3,(H,8,9,10)/t15-,16-;/m1./s1
IUPAC Name
(11S,12R)-7-fluoro-11-(4-fluorophenyl)-12-(1-methyl-1H-1,2,4-triazol-5-yl)-2,3,10-triazatricyclo[7.3.1.0^{5,13}]trideca-1,5,7,9(13)-tetraen-4-one; 4-methylbenzene-1-sulfonic acid
SMILES
CC1=CC=C(C=C1)S(O)(=O)=O.CN1N=CN=C1[C@@H]1[C@H](NC2=C3C1=NNC(=O)C3=CC(F)=C2)C1=CC=C(F)C=C1
ChemSpider
32697413
ChEMBL
CHEMBL3137318
Wikipedia
Talazoparib
Predicted Properties
PropertyValueSource
Water Solubility0.101 mg/mLALOGPS
logP2.93ALOGPS
logP2.11Chemaxon
logS-3.6ALOGPS
pKa (Strongest Acidic)9.48Chemaxon
pKa (Strongest Basic)1.45Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count5Chemaxon
Hydrogen Donor Count2Chemaxon
Polar Surface Area84.2 Å2Chemaxon
Rotatable Bond Count3Chemaxon
Refractivity111.27 m3·mol-1Chemaxon
Polarizability35.82 Å3Chemaxon
Number of Rings6Chemaxon
Bioavailability1Chemaxon
Rule of FiveNoChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon